- Home
- AIMD vs BFRI Comparison
AIMD vs BFRI Comparison
Compare AIMD & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AIMD | BFRI |
|---|---|---|
| Founded | 1984 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2M | 8.4M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | AIMD | BFRI |
|---|---|---|
| Price | $1.95 | $0.82 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | 19.6K | ★ 424.7K |
| Earning Date | 03-06-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $113,037.00 | ★ $37,164,000.00 |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | N/A | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 178.19 | 5.11 |
| 52 Week Low | $1.61 | $0.54 |
| 52 Week High | $4.75 | $1.24 |
Technical Indicators
Market Signals| Indicator | AIMD | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 47.86 | 55.43 |
| Support Level | $1.86 | $0.77 |
| Resistance Level | $1.97 | $0.86 |
| Average True Range (ATR) | 0.12 | 0.08 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 87.50 | 83.64 |
Price Performance
Historical ComparisonAbout AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.